Blog

SafeBeat Receives Supplement Award for UCSF Phase II SBIR Grant. Advancing Dr. Margaret Ferrari’s Career Development.   SafeBeat has been awarded a supplement award as part of its Phase Il SBIR grant by the National Institutes of Health (NIH) – National Heart, Lung, and Blood Institute (NHLBI) and in collaboration with the University of California,… Continue reading SafeBeat Receives Supplement Award for UCSF Phase II SBIR Grant. Advancing Dr. Margaret Ferrari’s Career Development.

The SafeBeat Research team proudly participated in this year’s AF Symposium in Boston, commemorating three decades of pioneering advancements in atrial fibrillation (AF) care. The milestone event brought together leading experts, clinicians, and innovators committed to cardiac research and treatment. During the symposium, SafeBeat Rx presented three new abstracts: The SafeBeat delegation engaged in thoughtful… Continue reading SafeBeat Celebrates AI-ECG Innovation at Annual AF Symposium, Presents Three New Abstracts

SafeBeat Awarded $2M SBIR Grant to Advance AI-based ECG Analysis for Mobile Therapeutic Monitoring of Atrial Fibrillation Patients: Clinical Study at University of California San Francisco   SafeBeat announced today it has been awarded a Direct to Phase Il Small Business Innovation Research (SBIR grant for approximately $2M from the National Heart, Lung, and Blood… Continue reading SafeBeat Awarded $2M SBIR Grant to Advance AI-based ECG Analysis for Mobile Therapeutic Monitoring of Atrial Fibrillation Patients: Clinical Study at University of California San Francisco

Dr. Rachita Navara expressed her pride in representing #HRX2023 as she highlighted the significance of having a dedicated conference for heart rhythm innovation within the field of EP cardiology. She acknowledged the fortunate opportunity for experts in this specialized area to convene and collaborate, sharing their insights and advancements all under one roof. This sentiment… Continue reading The HRX Welcome Xperience

Thrilled to share the highlights of our CEO, Dr. Rachita Navara, MD, FACC as she played a pivotal role in shaping the event’s dynamic discussions. Dr. Navara not only wrapped up HRX as a panelist, delving into innovative Home Care Models, but also co-chaired the ACC EP AI/Innovation Committee. Her expertise and leadership were instrumental… Continue reading HRX Innovators at heart

Dr. Kunj Patel and Dr. Rachita Navara immersed themselves in the latest advancements in digital health. They have been a part of this thrilling convergence of innovation, technology, and healthcare, all with a singular focus: revolutionizing EP cardiology. The conference provided an invaluable platform for networking, sharing ideas, and learning from the brightest minds in… Continue reading #HRX2023

CEO, Dr. Rachita Navara, a prominent member of the ACC EP council, was featured in a special podcast episode dedicated to Atrial Fibrillation (AFib) Awareness Month. The podcast offered an insightful journey into the world of digital health, wearable technology, and the future of patient-centered AFib management. She shared her expertise and vision for leveraging… Continue reading Explore Current Research and Get the Latest in Clinical Education

CEO, Dr. Rachita Navara, and CTO, Dr. Kunj Patel, took the stage as featured panel speakers. The event was an exciting opportunity that delved into the world of healthcare innovation. Dr. Rachita Navara and Dr. Kunj Patel, both experts in their fields, shared their valuable insights and experiences on turning visionary ideas into impactful ventures… Continue reading Innovating Healthcare: From Vision to Venture

Dr. Rachita Navara, CEO and cofounder of Safebeat Rx, had an informative webinar on Atrial Fibrillation (AFib) management, treatment and prevention for patients and families.  Her presentation aimed to empower patients and their families with knowledge about this common heart rhythm disorder. This insightful event was hosted by the American College of Cardiology Electrophysiology Council.

In March, we began our UCSF clinical trial, which focuses on obtaining real user feedback on our application and reviewing algorithm results against the UCSF providers. The SafeBeat application aims to streamline provider and patient communication by providing an analysis on data acquired from FDA cleared hardware. To date, we have successfully enrolled several patients… Continue reading SafeBeat Rx UCSF Clinical Trial begins Enrollment